Physician profile
Savannah Schaffer
NPI 1699507863
$702.55
in general payments reported to CMS, 2019-2025
16 companies · $703 in 2025
The $703 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $90.06 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $74.61 | 2025 | Bexsero, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $74.01 | 2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $66.28 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $64.81 | 2025 | Ozempic, Rybelsus |
| Alexion Pharmaceuticals, INC. | $63.58 | 2025 | Strensiq |
| Abbvie INC. | $45.74 | 2025 | |
| Agios Pharmaceuticals, INC. | $38.32 | 2025 | Pyrukynd |
| Pfizer INC. | $34.38 | 2025 | |
| Currax Pharmaceuticals LLC | $32.16 | 2025 | Contrave |
| Novartis Pharmaceuticals Corporation | $29.74 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.83 | 2025 | Jardiance |
| Corcept Therapeutics | $18.22 | 2025 | Korlym |
| Organon LLC | $18.05 | 2025 | Nexplanon |
| Amgen INC. | $17.00 | 2025 | Evenity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savannah Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.